We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$187M
Cap. Flow %
-3.95%
Top 10 Hldgs %
49.48%
Holding
1,228
New
25
Increased
10
Reduced
14
Closed
23

Top Buys

Rank Stock Value
1
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
+$5.9M
2
SPLK
Splunk Inc
SPLK
+$2.26M
3
COUP
Coupa Software Incorporated
COUP
+$2.15M
4
BKNG icon
Booking.com
BKNG
+$1.8M
5
PPLI
People Inc
PPLI
+$1.64M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.1M
2
Z icon
Zillow
Z
+$3.18M
3
AGN
Allergan plc
AGN
+$2.69M
4
RNG icon
RingCentral
RNG
+$2.07M
5
REXR icon
Rexford Industrial Realty
REXR
+$2.04M

Sector Composition

Rank Sector Weight
1 Real Estate 58.33%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMNX
1076
DELISTED
Luminex Corp
LMNX
$7K ﹤0.01%
254
– –
AKBA icon
1077
Akebia Therapeutics
AKBA
$343M
$6K ﹤0.01%
740
– –
BBWI icon
1078
Bath & Body Works
BBWI
$4.13B
$6K ﹤0.01%
599
– –
CHRS icon
1079
Coherus Oncology
CHRS
$225M
$6K ﹤0.01%
396
– –
EDIT icon
1080
Editas Medicine
EDIT
$411M
$6K ﹤0.01%
304
– –
ENTA icon
1081
Enanta Pharmaceuticals
ENTA
$370M
$6K ﹤0.01%
111
– –
HRB icon
1082
H&R Block
HRB
$5.37B
$6K ﹤0.01%
419
– –
MYGN icon
1083
Myriad Genetics
MYGN
$515M
$6K ﹤0.01%
420
– –
TWST icon
1084
Twist Bioscience
TWST
$5.39B
$6K ﹤0.01%
211
– –
WNS
1085
DELISTED
WNS Holdings
WNS
$6K ﹤0.01%
150
– –
YMAB
1086
DELISTED
Y-mAbs Therapeutics
YMAB
$6K ﹤0.01%
224
– –
ITCI
1087
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6K ﹤0.01%
364
– –
TCDA
1088
DELISTED
Tricida, Inc. Common Stock
TCDA
$6K ﹤0.01%
280
– –
ZGNX
1089
DELISTED
Zogenix, Inc.
ZGNX
$6K ﹤0.01%
250
– –
ESPR
1090
DELISTED
Esperion Therapeutics
ESPR
$5K ﹤0.01%
154
– –
SUPN icon
1091
Supernus Pharmaceuticals
SUPN
$2.73B
$5K ﹤0.01%
296
– –
RVNC
1092
DELISTED
Revance Therapeutics, Inc.
RVNC
$5K ﹤0.01%
317
– –
AXNX
1093
DELISTED
Axonics, Inc. Common Stock
AXNX
$5K ﹤0.01%
192
– –
NGM
1094
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$5K ﹤0.01%
376
– –
NSTG
1095
DELISTED
NanoString Technologies, Inc.
NSTG
$5K ﹤0.01%
202
– –
AIMT
1096
DELISTED
Aimmune Therapeutics
AIMT
$5K ﹤0.01%
357
– –
ADVM
1097
DELISTED
Adverum Biotechnologies
ADVM
$4K ﹤0.01%
44
– –
AEO icon
1098
PUT
American Eagle Outfitters
AEO
$2.98B
$4K ﹤0.01%
+863
New +$8.16K
AMPH icon
1099
Amphastar Pharmaceuticals
AMPH
$846M
$4K ﹤0.01%
265
– –
CERS icon
1100
Cerus
CERS
$615M
$4K ﹤0.01%
871
– –
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2020 Portfolio in Review

As of Q2 2020, Daiwa Securities Group held 1,228 positions worth $4.74B, down 51% from $9.64B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Daiwa Securities Group withdrew a net $187M in Q2 2020, closing 23 positions and reducing 14 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Daiwa Securities Group opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $6.27M.

  • Daiwa Securities Group's largest Q2 2020 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 5,000 shares worth $6.27M.
  • Daiwa Securities Group added most to Splunk Inc in Q2 2020, an estimated $2.26M increase.
  • Daiwa Securities Group's biggest Q2 2020 reduction was Zillow, cutting an estimated $3.18M.
  • Daiwa Securities Group fully exited Berkshire Hathaway Class B in Q2 2020, selling an estimated $11.1M.
  • Daiwa Securities Group's ten largest holdings make up 49% of its $4.74B portfolio in Q2 2020.
  • Daiwa Securities Group opened 25 new positions and closed 23 in Q2 2020.
  • Daiwa Securities Group's portfolio value fell 51% quarter-over-quarter to $4.74B.

Based on Daiwa Securities Group's 13F filing for Q2 2020, filed 11 Aug 2020.